Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × DILI × ribociclib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 40 Glioma 6 Neoplasm Metastasis 5 Glioblastoma 5 Neoplasms 4 Brain Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Sarcoma 3 Ovarian Neoplasms 3 Liposarcoma 3 Diffuse Intrinsic Pontine Glioma 3 Astrocytoma 3 Recurrence 2 Prostatic Neoplasms 2 Fallopian Tube Neoplasms 2 Breast Neoplasms, Male 2 Breast Cancer Metastatic 2 Venous Thromboembolism 1 Triple Negative Breast Neoplasms 1 Thymus Neoplasms 1 Sarcoma, Synovial 1 Rhabdoid Tumor 1 Pyloric Stenosis, Hypertrophic 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pinealoma 1 Oligodendroglioma 1 Non functioning pancreatic endocrine tumor 1 Neurofibrosarcoma 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors, Primitive 1

Interventions

ribociclib 1 palbociclib 1 abemaciclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06367335 2024-04-16

ETIC

University of Milano Bicocca

DILI

Data powered by HemOnc (CC BY 4.0) Colophon ⚡